(Q44577548)

English

Immunoprophylaxis with Simulect (basiliximab) in pediatric kidney transplant recipients: results from routine clinical practice at 5 kidney transplant units

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Immunoprophylaxis with Simulect (basiliximab) in pediatric kidney transplant recipients: results from routine clinical practice at 5 kidney transplant units (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

C García Meseguer

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A Vila López

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A Luque de Pablos

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A Vallo Boado

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

J M Simon

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Pediatric EOSS Study Group

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1697-1698

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900578-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900578-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900578-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900578-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900578-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0041-1345(03)00578-5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

release_fterk72uifhuhfq3hlmu4nco5u

1 reference

https://api.fatcat.wiki/v0/release/fterk72uifhuhfq3hlmu4nco5u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44577548&oldid=2028592816"